AVANAFIL (avanafil) by Hetero is phosphodiesterase 5 inhibitors [moa]. Approved for erectile dysfunction in adult males, erectile dysfunction ( ). First approved in 2024.
Drug data last refreshed 18h ago
Phosphodiesterase 5 Inhibitors
Phosphodiesterase 5 Inhibitor
Efficacy and Tolerability Study of Avanafil in Russia
Study Evaluating the Effects of Avanafil on Semen Parameters
This Study is to Evaluate the Safety and Efficacy of Avanafil in the Treatment of Erectile Dysfunction.
Study the Effect of Avanafil on the Pharmacodynamics and Pharmacokinetics of Warfarin in Healthy Male Subjects
Drug Interaction Study of Avanafil and Enalapril or Amlodipine
Worked on AVANAFIL at Hetero? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.